Welcome to our dedicated page for HYPERFINE SEC filings (Ticker: HYPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hyperfine, Inc. filings document a Nasdaq-listed medical device company built around the Swoop® portable MR brain imaging system and related Optive AI™ software. Its Form 8-K reports cover operating results, business updates, preliminary unaudited financial information, investor presentations, and material definitive agreements, including a senior secured term loan facility used for working capital and general corporate purposes.
Proxy materials describe annual meeting matters, governance procedures, and shareholder voting. The filing record also identifies HYPR Class A common stock registered on Nasdaq and provides capital-structure and corporate-governance disclosures tied to commercialization of portable brain MRI.
Hyperfine, Inc. (HYPR) launched a primary offering of Class A common stock and, in lieu of shares to certain investors, pre-funded warrants under its effective S-3 shelf. Lake Street is acting as sole book-runner, and the underwriters have a 15% option for additional securities.
The company intends to use proceeds for working capital and general corporate purposes, including commercial, manufacturing, and R&D activities. Pre-funded warrants are priced at the share offering price minus $0.0001 and carry a $0.0001 exercise price, are not exchange-listed, and include 4.99% or 9.99% beneficial ownership limits (adjustable with notice). Company lock-up is 90 days; directors and officers are subject to 60 days.
Management disclosed preliminary Q3 2025 revenue of approximately $3.4 million and cash and cash equivalents of approximately $21.6 million as of September 30, 2025. HYPR last closed at $2.05 on October 14, 2025. Shares outstanding were 63,525,713 Class A and 15,055,288 Class B as of June 30, 2025.
Hyperfine, Inc. (HYPR) launched a primary offering of Class A common stock and, in lieu of shares to certain investors, pre-funded warrants under its effective S-3 shelf. Lake Street is acting as sole book-runner, and the underwriters have a 15% option for additional securities.
The company intends to use proceeds for working capital and general corporate purposes, including commercial, manufacturing, and R&D activities. Pre-funded warrants are priced at the share offering price minus $0.0001 and carry a $0.0001 exercise price, are not exchange-listed, and include 4.99% or 9.99% beneficial ownership limits (adjustable with notice). Company lock-up is 90 days; directors and officers are subject to 60 days.
Management disclosed preliminary Q3 2025 revenue of approximately $3.4 million and cash and cash equivalents of approximately $21.6 million as of September 30, 2025. HYPR last closed at $2.05 on October 14, 2025. Shares outstanding were 63,525,713 Class A and 15,055,288 Class B as of June 30, 2025.
Hyperfine, Inc. (HYPR) reporting person Thomas Teisseyre, Chief Operating Officer and Director, reported a sale of Class A common stock on 08/18/2025. The Form 4 shows 1,151 shares were sold at $1.33 per share to satisfy tax withholding obligations tied to restricted stock units granted on March 28, 2022 and April 28, 2022. After the reported sale, Mr. Teisseyre beneficially owned 381,062 shares. The sale was executed under a "sell to cover" provision in the RSU agreement and the form was signed by an attorney-in-fact.
Hyperfine, Inc. furnished a press release announcing results for the second quarter ended June 30, 2025 and provided a business update; the press release is attached as Exhibit 99.1 to this Form 8-K.
The filing states the furnished material is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference. The company lists its Class A common stock (HYPR) on The Nasdaq Stock Market and indicates it is an emerging growth company. The report is signed by Brett Hale in his capacities as Chief Administrative Officer and Chief Financial Officer.
Hyperfine, Inc. (HYPR) received a Nasdaq notice on April 30, 2025 that its closing bid price fell below the $1.00 minimum for 30 consecutive business days and therefore did not meet Nasdaq Listing Rule 5450(a)(1). On August 6, 2025, Nasdaq notified the Company that it has regained compliance with the bid-price requirement and the matter is closed.
Key facts:
- Nasdaq deficiency notice: April 30, 2025
- Regained compliance and matter closed: August 6, 2025
- Ticker: HYPR; security: Class A common stock on the Nasdaq Global Market